Targeting gut microbiota with dietary components on cancer: Effects and potential mechanisms of action

Critical Reviews in Food Science and Nutrition

Volumn 60, Issue 6, 2020, Pages 1025-1037

  Tao, Jun ^a   Li, Sha ^b   Gan, Ren You ^c   Zhao, Cai Ning ^a   Meng, Xiao ^a   Li, Hua Bin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

cancer; cancer prevention; diet; fibers; Gut bacteria; phytochemicals

Indexed keywords

CHEMOTHERAPY; FATTY ACIDS; FIBERS; NUTRITION;

BIOACTIVE COMPOUNDS; CANCER; CANCER CHEMOTHERAPY; CANCER PREVENTION; GUT BACTERIA; PHYTOCHEMICALS; SHORT-CHAIN FATTY ACIDS; UPDATED INFORMATIONS;

DISEASES;

PHYTOCHEMICAL; PREBIOTIC AGENT; VOLATILE FATTY ACID;

DIET; DIETARY FIBER; HUMAN; INTESTINE FLORA; NEOPLASM;

DIET; DIETARY FIBER; FATTY ACIDS, VOLATILE; GASTROINTESTINAL MICROBIOME; HUMANS; NEOPLASMS; PHYTOCHEMICALS; PREBIOTICS;

EID: 85080840688     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2018.1555789     Document Type: Review

References (136)

1. Ahn, J., R., Sinha, Z., Pei, C., Dominianni, J., Wu, J., Shi, J. J., Goedert, R. B., Hayes, and L., Yang. 2013. Human gut microbiome and risk for colorectal cancer. Journal of the National Cancer Institute 105 (24):1907–1911.
2. Arumugam, M., J., Raes, E., Pelletier, D., Le Paslier, T., Yamada, D. R., Mende, G. R., Fernandes, J., Tap, T., Bruls, J. M., Batto, et al. 2011. Enterotypes of the human gut microbiome. Nature 473 (7346):174–180.
3. Benno, Y., K., Endo, H., Miyoshi, T., Okuda, H., Koishi, and T., Mitsuoka. 1989. Effect of rice fiber on human fecal microflora. Microbiology and Immunology 33 (5):435–440. doi: 10.1111/j.1348-0421.1989.tb01992.x.
4. Bertrand, R., G., Vancheswaran, D., Romain, Z., Laurence, A. W., Jennifer, and K., Guido. 2018. The gut microbiota influences anticancer immunosurveillance and general health. Nature Reviews Clinical Oncology 15:382–396.
5. Bindels, L. B., P., Porporato, E. M., Dewulf, J., Verrax, A. M., Neyrinck, J. C., Martin, K. P., Scott, P., Buc Calderon, O., Feron, G. G., Muccioli, et al. 2012. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. British Journal of Cancer 107 (8):1337–1344. doi: 10.1038/bjc.2012.409.
6. Brandi, G., S., De Lorenzo, M., Candela, M. A., Pantaleo, S., Bellentani, F., Tovoli, G., Saccoccio, and G., Biasco. 2017. Microbiota, NASH, HCC and the potential role of probiotics. Carcinogenesis 38 (3):231–240.
7. Bray, F., J., Ferlay, I., Soerjomataram, R. L., Siegel, L. A., Torre, and A., Jemal. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 68 (6):394–424. doi: 10.3322/caac.21492.
8. Bull-Otterson, L., W., Feng, I., Kirpich, Y., Wang, X., Qin, Y., Liu, L., Gobejishvili, S., Joshi-Barve, T., Ayvaz, J., Petrosino, et al. 2013. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS One 8 (1):e53028. Article No. doi: 10.1371/journal.pone.0053028.
9. Cardona, F., C., Andres-Lacueva, S., Tulipani, F. J., Tinahones, and M., Isabel Queipo-Ortuno. 2013. Benefits of polyphenols on gut microbiota and implications in human health. The Journal of Nutritional Biochemistry 24 (8):1415–1422. doi: 10.1016/j.jnutbio.2013.05.001.
10. Castellarin, M., R. L., Warren, J. D., Freeman, L., Dreolini, M., Krzywinski, J., Strauss, R., Barnes, P., Watson, E., Allen-Vercoe, R. A., Moore, and R. A., Holt. 2012. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Research 22 (2):299–306. doi: 10.1101/gr.126516.111.
11. Chan, C. L., R. Y., Gan, N. P., Shah, and H., Corke. 2018. Polyphenols from selected dietary spices and medicinal herbs differentially affect common food-borne pathogenic bacteria and lactic acid bacteria. Food Control 92:437–443. doi: 10.1016/j.foodcont.2018.05.032.
12. Chen, W. Y., B., Rosner, S. E., Hankinson, G. A., Colditz, and W. C., Willett. 2011. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA 306 (17):1884–1890. doi: 10.1001/jama.2011.1590.
13. Chlebowski, R. T., T. E., Rohan, J. E., Manson, A. K., Aragaki, A., Kaunitz, M. L., Stefanick, M. S., Simon, K. C., Johnson, J., Wactawski-Wende, M. J., O'Sullivan, et al. 2015. Breast cancer after use of estrogen plus progestin and estrogen alone: Analyses of data from 2 women’s health initiative randomized clinical trials. JAMA Oncology 1 (3):296–305. doi: 10.1001/jamaoncol.2015.0494.
14. Claesson, M. J., I. B., Jeffery, S., Conde, S. E., Power, E. M., O’Connor, S., Cusack, H. M. B., Harris, M., Coakley, B., Lakshminarayanan, O., O’Sullivan, et al. 2012. Gut microbiota composition correlates with diet and health in the elderly. Nature 488 (7410):178–179., doi: 10.1038/nature11319.
15. Clemente, J. C., L. K., Ursell, L. W., Parfrey, and R., Knight. 2012. The impact of the gut microbiota on human health: An integrative view. Cell 148 (6):1258–1270.
16. Clements, S. J., and S. R., Carding. 2018. Diet, the intestinal microbiota, and immune health in aging. Critical Reviews in Food Science and Nutrition 58 (4):651–661.
17. Cole, C. B., R., Fuller, A. K., Mallet, and I. R., Rowland. 1985. The influence of the host on expression of intestinal microbial enzyme activities involved in metabolism of foreign compounds. Journal of Applied Bacteriology 59 (6):549–553. doi: 10.1111/j.1365-2672.1985.tb03359.x.
18. Coppe, J. P., C. K., Patil, F., Rodier, Y., Sun, D. P., Munoz, J., Goldstein, P. S., Nelson, P. Y., Desprez, and J., Campisi. 2008. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biology 6:2853–2868.
19. Cummings, J. H., E. W., Pomare, W. J., Branch, C. P., Naylor, and G. T., Macfarlane. 1987. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28 (10):1221–1227. doi: 10.1136/gut.28.10.1221.
20. Dapito, D. H., A., Mencin, G. Y., Gwak, J. P., Pradere, M. K., Jang, I., Mederacke, J. M., Caviglia, H., Khiabanian, A., Adeyemi, R., Bataller, et al. 2012. Promotion of hepatocellular carcinoma by the intestinal microbiota and tlr4. Cancer Cell 21 (4):504–516. doi: 10.1016/j.ccr.2012.02.007.
21. de Filippo, C., D., Cavalieri, M., Di Paola, M., Ramazzotti, J. B., Poullet, S., Massart, S., Collini, G., Pieraccini, and P., Lionetti. 2010. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proceedings of the National Academy of Sciences of the United States of America 107 (33):14691–14696. doi: 10.1073/pnas.1005963107.
22. de Martel, C., J., Ferlay, S., Franceschi, J., Vignat, F., Bray, D., Forman, and M., Plummer. 2012. Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. The Lancet Oncology 13 (6):607–615. doi: 10.1016/S1470-2045(12)70137-7.
23. de Moreno, D. L. A., and G., Perdigon. 2010. The application of probiotic fermented milks in cancer and intestinal inflammation. Proceedings of the Nutrition Society 69:421–428.
24. Desai, M. S., A. M., Seekatz, N. M., Koropatkin, N., Kamada, C. A., Hickey, M., Wolter, N. A., Pudlo, S., Kitamoto, N., Terrapon, A., Muller, et al. 2016. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167 (5):1339–1348. doi: 10.1016/j.cell.2016.10.043.
25. Dorgan, J. F., D. J., Baer, P. S., Albert, J. T., Judd, E. D., Brown, D. K., Corle, W. S., Campbell, T. J., Hartman, A. A., Tejpar, B. A., Clevidence, et al. 2001. Serum hormones and the alcohol-breast cancer association in postmenopausal women. Journal of the National Cancer Institute 93 (9):710–715. doi: 10.1093/jnci/93.9.710.
26. Druart, C., L. B., Bindels, R., Schmaltz, A. M., Neyrinck, P. D., Cani, J., Walter, A. E., Ramer-Tait, and N. M., Delzenne. 2015. Ability of the gut microbiota to produce PUFA-derived bacterial metabolites: Proof of concept in germ-free versus conventionalized mice. Molecular Nutrition & Food Research 59 (8):1603–1613. doi: 10.1002/mnfr.201500014.
27. Elfert, A., L., Abo Ali, S., Soliman, S., Ibrahim, and S., Abd-Elsalam. 2016. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis. European Journal of Gastroenterology & Hepatology 28 (12):1450–1454. doi: 10.1097/MEG.0000000000000724.
28. Enright, E. F., B. T., Griffin, C. G. M., Gahan, and S. A., Joyce. 2018. Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism. Pharmacological Research 133:170–186.
29. Fan, P., L., Li, A., Rezaei, S., Eslamfam, D., Che, and X., Ma. 2015. Metabolites of dietary protein and peptides by intestinal microbes and their impacts on gut. Current Protein & Peptide Science 16 (7):646–654.
30. Fan, S., Q., Meng, B., Gao, J., Grossman, M., Yadegari, I. D., Goldberg, and E. M., Rosen. 2000. Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Research 60:5635–5639.
31. Fernandez, J., M., Navasa, R., Planas, S., Montoliu, D., Monfort, G., Soriano, C., Vila, A., Pardo, E., Quintero, V., Vargas, et al. 2007. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133:818–824. doi: 10.1053/j.gastro.2007.06.065.
32. Fleschhut, J., F., Kratzer, G., Rechkemmer, and S. E., Kulling. 2006. Stability and biotransformation of various dietary anthocyanins in vitro. European Journal of Nutrition 45 (1):7–18.
33. Friedman, S. L. 2008. Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiological Reviews 88 (1):125–172. doi: 10.1152/physrev.00013.2007.
34. Gan, R. Y., H. B., Li, A., Gunaratne, Z. Q., Sui, and H., Corke. 2017. Effects of fermented edible seeds and their products on human health: Bioactive components and bioactivities. Comprehensive Reviews in Food Science and Food Safety 16:489–531. doi: 10.1111/1541-4337.12257.
35. Gan, R. Y., H. B., Li, Z. Q., Sui, and H., Corke. 2018. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review. Critical Reviews in Food Science and Nutrition 58 (6):924–941. doi: 10.1080/10408398.2016.1231168.
36. Gao, Z., B., Guo, R., Gao, Q., Zhu, W., Wu, and H., Qin. 2015. Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer. Molecular Medicine Reports 12 (4):6119–6127. doi: 10.3892/mmr.2015.4124.
37. García-Villalba, R., D., Beltrán, J. C., Espín, M. V., Selma, and F. A., Tomás-Barberán. 2013. Time course production of urolithins from ellagic acid by human gut microbiota. Journal of Agricultural and Food Chemistry 61 (37):8797–8806.
38. Garrett, W. S. 2015. Cancer and the microbiota. Science (New York, N.Y.) 348 (6230):80–86.
39. Gentschew, L., and L. R., Ferguson. 2012. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Molecular Nutrition & Food Research 56 (4):524–535.
40. Gold, J. S., S., Bayar, and R. R., Salem. 2004. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Archives of Surgery 139 (7):760–765. doi: 10.1001/archsurg.139.7.760.
41. Goldin, B. R., H., Adlercreutz, S. L., Gorbach, J. H., Warram, J. T., Dwyer, L., Swenson, and M. N., Woods. 1982. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. New England Journal of Medicine 307 (25):1542–1547. doi: 10.1056/NEJM198212163072502.
42. Gorbach, S. L., and B. R., Goldin. 1987. Diet and the excretion and enterohepatic cycling of estrogens. Preventive Medicine 16 (4):525–531.
43. Guo, Y. J., G. F., Deng, X. R., Xu, S., Wu, S., Li, E. Q., Xia, F., Li, F., Chen, W. H., Ling, and H. B., Li. 2012. Antioxidant capacities, phenolic compounds and polysaccharide contents of 49 edible macro-fungi. Food & Function 3 (11):1195–1205. doi: 10.1039/c2fo30110e.
44. Gur, C., Y., Ibrahim, B., Isaacson, R., Yamin, J., Abed, M., Gamliel, J., Enk, Y., Bar-On, N., Stanietsky-Kaynan, S., Coppenhagen-Glazer, et al. 2015. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42 (2):344–355. doi: 10.1016/j.immuni.2015.01.010.
45. Hallam, M. C., D., Barile, M., Meyrand, J. B., German, and R. A., Reimer. 2014. Maternal high-protein or high-prebiotic-fiber diets affect maternal milk composition and gut microbiota in rat dams and their offspring. Obesity (Silver Spring, Md.) 22 (11):2344–2351.
46. Hervert-Hernandez, D., C., Pintado, R., Rotger, and I., Goni. 2009. Stimulatory role of grape pomace polyphenols on Lactobacillus acidophilus growth. International Journal of Food Microbiology 136:119–122. doi: 10.1016/j.ijfoodmicro.2009.09.016.
47. Hildebrandt, M. A., C., Hoffmann, S. A., Sherrill-Mix, S. A., Keilbaugh, M., Hamady, Y. Y., Chen, R., Knight, R. S., Ahima, F., Bushman, and G. D., Wu. 2009. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137 (5):1716–1724. doi: 10.1053/j.gastro.2009.08.042.
48. Isabel Queipo-Ortuno, M., M., Boto-Ordonez, M., Murri, J., Miguel Gomez-Zumaquero, M., Clemente-Postigo, R., Estruch, F., Cardona Diaz, C., Andres-Lacueva, and F. J., Tinahones. 2012. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. The American Journal of Clinical Nutrition 95:1323–1334. doi: 10.3945/ajcn.111.027847.
49. Joannou, G. E., G. E., Kelly, A. Y., Reeder, M., Waring, and C., Nelson. 1995. A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. The Journal of Steroid Biochemistry and Molecular Biology 54 (3–4):167–184.
50. Kado, S., K., Uchida, H., Funabashi, S., Iwata, Y., Nagata, M., Ando, M., Onoue, Y., Matsuoka, M., Ohwaki, and M., Morotomi. 2001. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Research 61:2395–2398.
51. Karlsson, F. H., V., Tremaroli, I., Nookaew, G., Bergstrom, C. J., Behre, B., Fagerberg, J., Nielsen, and F., Backhed. 2013. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498 (7452):99–103. doi: 10.1038/nature12198.
52. Kim, K. A., W., Gu, I. A., Lee, E. H., Joh, and D. H., Kim. 2012. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 7:e4771310. doi: 10.1371/journal.pone.0047713.
53. Kohler, B. A., R. L., Sherman, N., Howlader, A., Jemal, A. B., Ryerson, K. A., Henry, F. P., Boscoe, K. A., Cronin, A., Lake, A. M., Noone, et al. 2015. Annual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. Journal of the National Cancer Institute 107:djv048.
54. Kostic, A. D., D., Gevers, C. S., Pedamallu, M., Michaud, F., Duke, A. M., Earl, A. I., Ojesina, J., Jung, A. J., Bass, J., Tabernero, et al. 2012. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Research 22 (2):292–298. doi: 10.1101/gr.126573.111.
55. Kostic, A. D., E., Chun, L., Robertson, J. N., Glickman, C. A., Gallini, M., Michaud, T. E., Clancy, D. C., Chung, P., Lochhead, G. L., Hold, et al. 2013. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host & Microbe 14 (2):207–215. doi: 10.1016/j.chom.2013.07.007.
56. Kuilman, T., and D. S., Peeper. 2009. Senescence-messaging secretome: SMS-ing cellular stress. Nature Reviews. Cancer 9 (2):81–94.
57. Kwa, M., C. S., Plottel, M. J., Blaser, and S., Adams. 2016. The intestinal microbiome and estrogen receptor-positive female breast cancer. JNCI: Journal of the National Cancer Institute 108:djw029. doi: 10.1093/jnci/djw029.
58. Kwan, M. L., L. H., Kushi, E., Weltzien, E. K., Tam, A., Castillo, C., Sweeney, and B. J., Caan. 2010. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: The life after cancer epidemiology study. Journal of Clinical Oncology 28 (29):4410–4416. doi: 10.1200/JCO.2010.29.2730.
59. Kwong, T. N. Y., X., Wang, G., Nakatsu, T. C., Chow, T., Tipoe, R. Z. W., Dai, K. K. K., Tsoi, M. C. S., Wong, G., Tse, M. T. V., Chan, et al. 2018. Association between bacteremia from specific microbes and subsequent diagnosis of colorectal cancer. Gastroenterology 155 (2):383–390.e8. doi:10.1053/j.gastro.2018.04.028.
60. Lakritz, J. R., T., Poutahidis, T., Levkovich, B. J., Varian, Y. M., Ibrahim, A., Chatzigiagkos, S., Mirabal, E. J., Alm, and S. E., Erdman. 2014. Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice. International Journal of Cancer 135 (3):529–540. doi: 10.1002/ijc.28702.
61. Larrosa, M., C., Luceri, E., Vivoli, C., Pagliuca, M., Lodovici, G., Moneti, and P., Dolara. 2009. Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. Molecular Nutrition & Food Research 53 (8):1044–1054. doi: 10.1002/mnfr.200800446.
62. Le Chatelier, E., T., Nielsen, J., Qin, E., Prifti, F., Hildebrand, G., Falony, M., Almeida, M., Arumugam, J. M., Batto, S., Kennedy, et al. 2013. Richness of human gut microbiome correlates with metabolic markers. Nature 500 (7464):541–546. doi: 10.1038/nature12506.
63. Le, M. G., L. H., Moulton, C., Hill, and A., Kramar. 1986. Consumption of dairy produce and alcohol in a case-control study of breast cancer. JNCI: Journal of the National Cancer Institute 77:633–636. doi: 10.1093/jnci/77.3.633.
64. Lee, H. C., A. M., Jenner, C. S., Low, and Y. K., Lee. 2006. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Research in Microbiology 157 (9):876–884. doi: 10.1016/j.resmic.2006.07.004.
65. Lew, J. Q., N. D., Freedman, M. F., Leitzmann, L. A., Brinton, R. N., Hoover, A. R., Hollenbeck, A., Schatzkin, and Y., Park. 2009. Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women: The NIH-AARP Diet and Health Study. American Journal of Epidemiology 170 (3):308–317. doi: 10.1093/aje/kwp120.
66. Li, C. I., R. T., Chlebowski, M., Freiberg, K. C., Johnson, L., Kuller, D., Lane, L., Lessin, M. J., O'Sullivan, J., Wactawski-Wende, S., Yasmeen, and R., Prentice. 2010. Alcohol consumption and risk of postmenopausal breast cancer by subtype: The women’s health initiative observational study. Journal of the National Cancer Institute 102 (18):1422–1431. doi: 10.1093/jnci/djq316.
67. Li, F., S., Li, H. B., Li, G. F., Deng, W. H., Ling, and X. R., Xu. 2013a. Antiproliferative activities of tea and herbal infusions. Food & Function 4 (4):530–538.
68. Li, F., S., Li, H. B., Li, G. F., Deng, W. H., Ling, S., Wu, X. R., Xu, and F., Chen. 2013b. Antiproliferative activity of peels, pulps and seeds of 61 fruits. Journal of Functional Foods 5 (3):1298–1309. doi: 10.1016/j.jff.2013.04.016.
69. Li, Y., J. J., Zhang, D. P., Xu, T., Zhou, Y., Zhou, S., Li, and H. B., Li. 2016a. Bioactivities and health benefits of wild fruits. International Journal of Molecular Sciences 17 (8):1258. doi: 10.3390/ijms17081258.
70. Li, J., C. Y., Sung, N., Lee, Y., Ni, J., Pihlajamaki, G., Panagiotou, and H., El-Nezami. 2016b. Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proceedings of the National Academy of Sciences 113 (9):E1306–E1315. doi: 10.1073/pnas.1518189113.
71. Li, Y., S., Li, X., Meng, R. Y., Gan, J. J., Zhang, and H. B., Li. 2017. Dietary natural products for prevention and treatment of breast cancer. Nutrients 9 (7):728. doi: 10.3390/nu9070728.
72. Lin, J., S. M., Zhang, N. R., Cook, K. M., Rexrode, S., Liu, J. E., Manson, I. M., Lee, and J. E., Buring. 2005. Dietary intakes of fruit, vegetables, and fiber, and risk of colorectal cancer in a prospective cohort of women (United States). Cancer Causes & Control 16 (3):225–233. doi: 10.1007/s10552-004-4025-1.
73. Liu, R., J., Hong, X., Xu, Q., Feng, D., Zhang, Y., Gu, J., Shi, S., Zhao, W., Liu, X., Wang, et al. 2017. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nature Medicine 23 (7):859–868. doi: 10.1038/nm.4358.
74. Louis, P., G. L., Hold, and H. J., Flint. 2014. The gut microbiota, bacterial metabolites and colorectal cancer. Nature Reviews Microbiology 12 (10):661–672. doi: 10.1038/nrmicro3344.
75. Lupton, J. R., and P. P., Kurtz. 1993. Relationship of colonic luminal short-chain fatty acids and pH to in vivo cell proliferation in rats. The Journal of Nutrition 123 (9):1522–1530.
76. Ma, C., M., Han, B., Heinrich, Q., Fu, Q., Zhang, M., Sandhu, D., Agdashian, M., Terabe, J. A., Berzofsky, V., Fako, et al. 2018. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science 360:876–882.
77. Macfarlane, G. T., and S., Macfarlane. 1997. Human colonic microbiota: Ecology, physiology and metabolic potential of intestinal bacteria. Scandinavian Journal of Gastroenterology 222:3–9. doi: 10.1080/00365521.1997.11720708.
78. Mariat, D., O., Firmesse, F., Levenez, V., Guimarăes, H., Sokol, J., Doré, G., Corthier, and J. P., Furet. 2009. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiology 9 (1):123. doi: 10.1186/1471-2180-9-123.
79. Maslowski, K. M., A. T., Vieira, A., Ng, J., Kranich, F., Sierro, D., Yu, H. C., Schilter, M. S., Rolph, F., Mackay, D., Artis, et al. 2009. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461:1282–1289.
80. McIntosh, G. H., P. J., Royle, and M. J., Playne. 1999. A probiotic strain of L. acidophilus reduces DMH-induced large intestinal tumors in male Sprague-Dawley rats. Nutrition and Cancer 35 (2):153–159. doi: 10.1207/S15327914NC352_9.
81. Meisel, M., R., Hinterleitner, A., Pacis, L., Chen, Z. M., Earley, T., Mayassi, J. F., Pierre, J. D., Ernest, H. J., Galipeau, N., Thuille, et al. 2018. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557 (7706):580–590. doi: 10.1038/s41586-018-0125-z.
82. Menni, C., C., Lin, M., Cecelja, M., Mangino, M. L., Matey-Hernandez, L., Keehn, R. P., Mohney, C. J., Steves, T. D., Spector, C. F., Kuo, et al. 2018. Gut microbial diversity is associated with lower arterial stiffness in women. European Heart Journal 39 (25):2390–2397. doi:10.1093/eurheartj/ehy226.
83. Mima, K., S., Nakagawa, H., Sawayama, T., Ishimoto, K., Imai, M., Iwatsuki, D., Hashimoto, Y., Baba, Y. I., Yamashita, N., Yoshida, et al. 2017. The microbiome and hepatobiliary-pancreatic cancers. Cancer Letters 402:9–15. doi: 10.1016/j.canlet.2017.05.001.
84. Molan, A., Z., Liu, and M., Kruger. 2010. The ability of blackcurrant extracts to positively modulate key markers of gastrointestinal function in rats. World Journal of Microbiology and Biotechnology 26 (10):1735–1743. doi: 10.1007/s11274-010-0352-4.
85. Mutlu, E. A., P. M., Gillevet, H., Rangwala, M., Sikaroodi, A., Naqvi, P. A., Engen, M., Kwasny, C. K., Lau, and A., Keshavarzian. 2012. Colonic microbiome is altered in alcoholism. American Journal of Physiology-Gastrointestinal and Liver Physiology 302 (9):G966–G978. doi: 10.1152/ajpgi.00380.2011.
86. Nakamura, J., Y., Kubota, M., Miyaoka, T., Saitoh, F., Mizuno, and Y., Benno. 2002. Comparison of four microbial enzymes in Clostridia and Bacteroides isolated from human feces. Microbiology and Immunology 46 (7):487–490. doi: 10.1111/j.1348-0421.2002.tb02723.x.
87. O'Keefe, S. J., J. V., Li, L., Lahti, J., Ou, F., Carbonero, K., Mohammed, J. M., Posma, J., Kinross, E., Wahl, E., Ruder, et al. 2015. Fat, fibre and cancer risk in African Americans and rural Africans. Nature Communications 6:6342.
88. O'Keefe, S. J. 2016. Diet, microorganisms and their metabolites, and Colon cancer. Nature Reviews Gastroenterology & Hepatology 13:691–706. doi: 10.1038/nrgastro.2016.165.
89. Ou, J., F., Carbonero, E. G., Zoetendal, J. P., DeLany, M., Wang, K., Newton, H. R., Gaskins, and S. J. D., O’Keefe. 2013. Diet, microbiota, and microbial metabolites in Colon cancer risk in rural Africans and African Americans. The American Journal of Clinical Nutrition 98 (1):111–120. doi: 10.3945/ajcn.112.056689.
90. Ozdal, T., D. A., Sela, J., Xiao, D., Boyacioglu, F., Chen, and E., Capanoglu. 2016. The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients 8 (2):78. Article No.doi: 10.3390/nu8020078.
91. Peek, R. M. J., and M. J., Blaser. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nature Reviews. Cancer 2 (1):28–37.
92. Peng, M., and D., Biswas. 2017. Short chain and polyunsaturated fatty acids in host gut health and foodborne bacterial pathogen inhibition. Critical Reviews in Food Science and Nutrition 57 (18):3987–4002. doi: 10.1080/10408398.2016.1203286.
93. Riboli, E., and T., Norat. 2003. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. The American Journal of Clinical Nutrition 78 (3 Suppl):559–569.
94. Ridlon, J. M., D. J., Kang, and P. B., Hylemon. 2006. Bile salt biotransformations by human intestinal bacteria. Journal of Lipid Research 47 (2):241–259.
95. Rowland, I. R., C. A., Bearne, R., Fischer, and B. L., Pool-Zobel. 1996. The effect of lactulose on DNA damage induced by DMH in the Colon of human flora-associated rats. Nutrition and Cancer 26 (1):37–47.
96. Rubinstein, M. R., X., Wang, W., Liu, Y., Hao, G., Cai, and Y. W., Han. 2013. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14 (2):195–206. doi: 10.1016/j.chom.2013.07.012.
97. Russell, W. R., A., Labat, L., Scobbie, and S. H., Duncan. 2007. Availability of blueberry phenolics for microbial metabolism in the Colon and the potential inflammatory implications. Molecular Nutrition & Food Research 51 (6):726–731. doi: 10.1002/mnfr.200700022.
98. Russell, W. R., L., Hoyles, H. J., Flint, and M., Dumas. 2013. Colonic bacterial metabolites and human health. Current Opinion in Microbiology 16 (3):246–254. doi: 10.1016/j.mib.2013.07.002.
99. Russo, J., and I. H., Russo. 2006. The role of estrogen in the initiation of breast cancer. The Journal of Steroid Biochemistry and Molecular Biology 102 (1–5):89–96.
100. Seitz, H. K., and B., Maurer. 2007. The relationship between alcohol metabolism, estrogen levels, and breast cancer risk. Alcohol Research & Health 30:42–43.
101. Setchell, K. D., N. M., Brown, and E., Lydeking-Olsen. 2002. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. The Journal of Nutrition 132 (12):3577–3584.
102. Shen, X. J., J. F., Rawls, T., Randall, L., Burcal, C. N., Mpande, N., Jenkins, B., Jovov, Z., Abdo, R. S., Sandler, and T. O., Keku. 2010. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 1 (3):138–147. doi: 10.4161/gmic.1.3.12360.
103. Sivan, A., L., Corrales, N., Hubert, J. B., Williams, K., Aquino-Michaels, Z. M., Earley, F. W., Benyamin, Y. M., Lei, B., Jabri, M. L., Alegre, et al. 2015. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350 (6264):1084–1089. doi: 10.1126/science.aac4255.
104. Smith, P. M., M. R., Howitt, N., Panikov, M., Michaud, C. A., Gallini, M., Bohlooly-Y, J. N., Glickman, and W. S., Garrett. 2013. The microbial metabolites, short-chain fatty acids, regulate colonic T-reg cell homeostasis. Science 341 (6145):569–573. doi: 10.1126/science.1241165.
105. Sobhani, I., Roudot-Thoraval Tap, J., F., Roperch, J. P., Letulle, S., Langella, P., Corthier, G., Tran, Van Nhieu, J., Furet. and J. P., 2011. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 6 (1):e16393. doi: 10.1371/journal.pone.0016393.
106. Song, M., and A. T., Chan. 2017. Diet, gut microbiota, and colorectal cancer prevention: A review of potential mechanisms and promising targets for future research. Current Colorectal Cancer Reports 13 (6):429–439. doi: 10.1007/s11888-017-0389-y.
107. Suzuki, R., N., Orsini, L., Mignone, S., Saji, and A., Wolk. 2008. Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status: A meta-analysis of epidemiological studies. International Journal of Cancer 122 (8):1832–1841. doi: 10.1002/ijc.23184.
108. Tao, J., Y., Li, S., Li, and H. B., Li. 2018. Plant foods for the prevention and management of Colon cancer. Journal of Functional Foods 42:95–110. doi: 10.1016/j.jff.2017.12.064.
109. Terry, P., E., Giovannucci, K. B., Michels, L., Bergkvist, H., Hansen, L., Holmberg, and A., Wolk. 2001. Fruit, vegetables, dietary fiber, and risk of colorectal cancer. Journal of the National Cancer Institute 93 (7):525–533.
110. Tomás-Navarro, M., F., Vallejo, E., Sentandreu, J. L., Navarro, and F. A., Tomás-Barberán. 2014. Volunteer stratification is more relevant than technological treatment in orange juice flavanone bioavailability. Journal of Agricultural and Food Chemistry 62 (1):24–27. doi: 10.1021/jf4048989.
111. Tuohy, K. M., D. J. S., Hinton, S. J., Davies, M. J. C., Crabbe, G. R., Gibson, and J. M., Ames. 2006. Metabolism of Maillard reaction products by the human gut microbiota: Implications for health. Molecular Nutrition & Food Research 50 (9):847–857. doi: 10.1002/mnfr.200500126.
112. Tzounis, X., J., Vulevic, G. G. C., Kuhnle, T., George, J., Leonczak, G. R., Gibson, C., Kwik-Uribe, and J. P. E., Spencer. 2008. Flavanol monomer-induced changes to the human faecal microflora. The British Journal of Nutrition 99 (4):782–792.
113. Tzounis, X., A., Rodriguez-Mateos, J., Vulevic, G. R., Gibson, C., Kwik-Uribe, and J. P. E., Spencer. 2011. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. The American Journal of Clinical Nutrition 93 (1):62–72. doi: 10.3945/ajcn.110.000075.
114. Van'T, V. P., J. M., Dekker, J. W., Lamers, F. J., Kok, E. G., Schouten, H. A., Brants, F., Sturmans, and R. J., Hermus. 1989. Consumption of fermented milk products and breast cancer: A case-control study in The Netherlands. Cancer Research 49 (14):4020–4023.
115. Vendrame, S., S., Guglielmetti, P., Riso, S., Arioli, D., Klimis-Zacas, and M., Porrini. 2011. Six-week consumption of a wild blueberry powder drink increases Bifidobacteria in the human gut. Journal of Agricultural and Food Chemistry 59 (24):12815–12820. doi: 10.1021/jf2028686.
116. Vetizou, M., J. M., Pitt, R., Daillere, P., Lepage, N., Waldschmitt, C., Flament, S., Rusakiewicz, B., Routy, M. P., Roberti, C. P. M., Duong, et al. 2015. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350 (6264):1079–1084. doi: 10.1126/science.aad1329.
117. Viaud, S., F., Saccheri, G., Mignot, T., Yamazaki, R., Daillere, D., Hannani, D. P., Enot, C., Pfirschke, C., Engblom, M. J., Pittet, et al. 2013. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342 (6161):971–976. doi: 10.1126/science.1240537.
118. Vlachogiannakos, J., N., Viazis, P., Vasianopoulou, I., Vafiadis, D. G., Karamanolis, and S. D., Ladas. 2013. Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis. Journal of Gastroenterology and Hepatology 28 (3):450–455. doi: 10.1111/jgh.12070.
119. Vogt, S. L., J., Pena-Diaz, and B. B., Finlay. 2015. Chemical communication in the gut: Effects of microbiota-generated metabolites on gastrointestinal bacterial pathogens. Anaerobe 34:106–115. doi: 10.1016/j.anaerobe.2015.05.002.
120. Wang, Z., E., Klipfell, B. J., Bennett, R., Koeth, B. S., Levison, B., Dugar, A. E., Feldstein, E. B., Britt, X., Fu, Y. M., Chung, et al. 2011. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472 (7341):57–63. doi: 10.1038/nature09922.
121. Wei, Z., S., Cao, S., Liu, Z., Yao, T., Sun, Y., Li, J., Li, D., Zhang, and Y., Zhou. 2016. Could gut microbiota serve as prognostic biomarker associated with colorectal cancer patients’ survival? A pilot study on relevant mechanism. Oncotarget 7:46158–46172.
122. Willett, W. C., M. J., Stampfer, G. A., Colditz, B. A., Rosner, C. H., Hennekens, and F. E., Speizer. 1987. Moderate alcohol consumption and the risk of breast cancer. The New England Journal of Medicine 316 (19):1174–1180.
123. Wu, G. D., J., Chen, C., Hoffmann, K., Bittinger, Y., Chen, S. A., Keilbaugh, M., Bewtra, D., Knights, W. A., Walters, R., Knight, et al. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (6052):105–108. doi: 10.1126/science.1208344.
124. Xiao, J., and P., Hogger. 2014. Advances in the pharmacokinetics of natural bioactive polyphenols. Current Drug Metabolism 15 (1):1–2. doi: 10.2174/1389200215666140130152644.
125. Yoshimoto, S., T. M., Loo, K., Atarashi, H., Kanda, S., Sato, S., Oyadomari, Y., Iwakura, K., Oshima, H., Morita, M., Hattori, et al. 2013. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499 (7456):97–101. doi: 10.1038/nature12347.
126. Yu, L., H., Yan, Q., Liu, W., Yang, H., Wu, W., Dong, L., Tang, Y., Lin, Y., He, S., Zou, et al. 2010. Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents. Hepatology 52 (4):1322–1333. doi: 10.1002/hep.23845.
127. Yu, L., and R. F., Schwabe. 2017. The gut microbiome and liver cancer: Mechanisms and clinical translation. Nature Reviews Gastroenterology & Hepatology 14 (9):527–539. doi: 10.1038/nrgastro.2017.72.
128. Zhang, Y. J., S., Li, R. Y., Gan, T., Zhou, D. P., Xu, and H. B., Li. 2015a. Impacts of gut bacteria on human health and diseases. International Journal of Molecular Sciences 16 (4):7493–7519.
129. Zhang, Y. J., R. Y., Gan, S., Li, Y., Zhou, A. N., Li, D. P., Xu, and H. B., Li. 2015b. Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules 20 (12):21138–21156.
130. Zhang, J. J., Y., Li, T., Zhou, D. P., Xu, P., Zhang, S., Li, and H. B., Li. 2016. Bioactivities and health benefits of mushrooms mainly from China. Molecules 21 (7):938. doi: 10.3390/molecules21070938.
131. Zheng, J., Y., Zhou, Y., Li, D. P., Xu, S., Li, and H. B., Li. 2016. Spices for prevention and treatment of cancers. Nutrients 8 (8):495. doi: 10.3390/nu8080495.
132. Zhou, Y., J., Zheng, Y., Li, D. P., Xu, S., Li, Y. M., Chen, and H. B., Li. 2016a. Natural polyphenols for prevention and treatment of cancer. Nutrients 8 (8):515. doi: 10.3390/nu8080515.
133. Zhou, Y., Y., Li, T., Zhou, J., Zheng, S., Li, and H. B., Li. 2016b. Dietary natural products for prevention and treatment of liver cancer. Nutrients 8 (3):156.
134. Zitvogel, L., R., Daillere, M. P., Roberti, B., Routy, and G., Kroemer. 2017. Anticancer effects of the microbiome and its products. Nature Reviews Microbiology 15 (8):465–478.
135. Zoetendal, E. G., M., Rajilic-Stojanovic, and W. M., de Vos. 2008. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57 (11):1605–1615. doi: 10.1136/gut.2007.133603.
136. Zubik, L., and M., Meydani. 2003. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. The American Journal of Clinical Nutrition 77 (6):1459–1465.